HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johna Lucas Selected Research

Flushing

1/2022Safety Profile of Bremelanotide Across the Clinical Development Program.
11/2019Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
11/2019Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johna Lucas Research Topics

Disease

9Psychological Sexual Dysfunctions (Sexual Arousal Disorder)
01/2022 - 09/2005
3Nausea
01/2022 - 11/2019
3Flushing
01/2022 - 11/2019
3Headache (Headaches)
01/2022 - 11/2019
1Hyperpigmentation
01/2022
1Injection Site Reaction
01/2022
1Body Weight (Weight, Body)
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Hypertension (High Blood Pressure)
01/2017

Drug/Important Bio-Agent (IBA)

8bremelanotideIBA
01/2022 - 01/2017
3Testosterone (Sustanon)FDA Link
01/2022 - 09/2005
2Melanocortin Receptors (Melanocortin Receptor)IBA
01/2022 - 03/2017
1Pharmaceutical PreparationsIBA
11/2019
1Hormones (Hormone)IBA
03/2017
1Melanocyte-Stimulating Hormones (MSH)IBA
03/2017
1Peptides (Polypeptides)IBA
03/2017
1thiamine triphosphorate (TTP)IBA
01/2011